Beruflich Dokumente
Kultur Dokumente
Should children and adults have one or Special groups aged 9 months or older
two chickenpox immunisations? Two vaccine doses are recommended and funded for infants,
Children aged less than 13 years children and adults who meet the eligibility criteria for one of
Parents may choose to purchase a second dose of the ‘special groups’ described in the Pharmaceutical Schedule.
varicella vaccine, which can be administered a minimum How long does vaccine protection last?
of 4 weeks before or after the first dose. Protection after two doses of vaccine appears to be very long
»» One dose gives good protection, two doses give term for most people immunised, however, it is not known if it is
optimal protection. lifelong at this stage. Countries that have been using the vaccine
Children aged 13 years or older and adults for a long time have not identified a need for booster doses.
The standard varicella vaccine schedule is two doses
administered a minimum of 4 weeks apart for individuals in
this age group receiving varicella vaccine for the first time.
Vaccines are prescription medicines. Talk to your doctor or nurse about the benefits or any risks.
References
• Ampofo K, Saiman L, LaRussa P, Steinberg S, Annunziato P, Gershon A. Persistence of immunity to live attenuated varicella
vaccine in healthy adults. Clin Infect Dis. 2002;34(6):774-9.
• Baxter R, Ray P, Tran TN, Black S, Shinefield HR, Coplan PM, et al. Long-term effectiveness of varicella Vaccine: A 14-year,
prospective cohort study. Pediatrics. 2013;131(5):138-1396.
• Centers for Disease Control and Prevention. Prevention of varicella recommendations of the Advisory Committee on
Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-04):1-40.
• Chaves SS, Haber P, Walton K, Wise RP, Izurieta HS, Schmid DS, et al. Safety of varicella vaccine after licensure in the United States:
Experience from reports to the Vaccine Adverse Event Reporting System, 1995–2005. J Infect Dis. 2008;197(Suppl 2):S170-7.
• Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, et al. The incidence and clinical characteristics of herpes zoster
among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J. 2009;28(11):954-9.
• Gershon AA, Gershon MD. Pathogenesis and current approaches to control of varicella-zoster virus infections. Clin Microbiol
Rev. 2013;26(4):728-43.
• Heininger U, Seward JF. Varicella. Lancet. 2006;368(9544):1365-76. Tarlow MJ, Walters S. Chickenpox in childhood: A review prepared for
the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect. 1998;36(Suppl 1):39-47.
• Levin MJ, Murray M, Zerbe GO, White CJ, Hayward AR. Immune responses of elderly persons 4 years after receiving a live
attenuated varicella vaccine. J Infect Dis. 1994;170(3):522-6.
• Macartney K, McIntyre P. Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults.
Cochrane Database Syst Rev. 2008;(3):Art. No.: CD001833.
• Ministry of Health. Immunisation handbook 2017. Wellington:Ministry of Health; 2017.
• Ozaki T, Nishimura N, Muto T, Sugata K, Kawabe S, Goto K, et al. Safety and immunogenicity of gelatin-free varicella
vaccine in epidemiological and serological studies in Japan. Vaccine. 2005;23(10):1205-8. Pace D. Review of varicella
zoster virus: From epidemiology to prevention. Malta Medical Journal. 2008;20(3):7-11.
• Schmid DS, Jumaan AO. Impact of varicella vaccine on varicella-zoster virus dynamics. Clin Microbiol Rev. 2010;23(1):202-17.
• Wutzler P, Knuf M, Liese J. Varicella: Efficacy of two-dose vaccination in childhood. Dtsch Arztebl Int. 2008;105(33):567-72.